Last updated on September 2018

Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases

Brief description of study

The objective of this study is to evaluate the effect of adalimumab on health outcomes in participants with rheumatoid arthritis, ankylosing spondylitis and plaque psoriasis.

Clinical Study Identifier: NCT03339089

Contact Investigators or Research Sites near you

Start Over

Sun Fang

AbbVie China /ID# 164373
Chengdu, China
  Connect »